ClearCam, an Austin, TX-based company dedicated to maximizing surgical visualization and proficiency in the operating room, raised $4M in Seed Series 3 funding.
The round was led by the Family Office of Texas real estate developer Hal Jones and joined by the University of Texas at Austin Seed Fund and other investors.
The company intends to use the funds to expand their sales and business development initiatives, and invest in robotic surgery.
Led by CEO John Uecker, and CTO Dr. Chris Idelson, ClearCam is dedicated to improving laparoscopic surgery patient outcomes by reducing surgical team frustration, shortening surgical procedures, and lowering costs. Its ClearScope™ is a disposable in-vivo laparoscopic lens cleaner, which eliminates the need for clinicians to continually remove and clean a scope during surgery. ClearScope™ enables surgeons to maintain their visual field and momentum throughout surgery, reduces a patient’s time in the OR, and maximizes surgical excellence while improving surgical safety. The device has been used in close to 2000 procedures across the country and is gaining traction in thoracic, general, and gynecologic surgeries.
ClearScope™ is available in several hospital systems in Texas and Michigan with a long list of systems awaiting access and trials across the country.
The company is an affiliate/alum of Dell Medical School and Cockrell School of Engineering at the University of Texas at Austin, Texas Venture Labs, Texas Health Catalyst, Austin Technology Incubator, and MedTech Innovator Accelerator.
FinSMEs
17/05/2023